Atria Investments’s Columbia Research Enhanced Core ETF RECS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.5M Sell
192,402
-2,922
-1% -$119K 0.08% 258
2025
Q4
$7.98M Sell
195,324
-13,696
-7% -$557K 0.09% 243
2025
Q3
$8.43M Buy
209,020
+18,804
+10% +$725K 0.1% 235
2025
Q2
$7M Buy
190,216
+11,029
+6% +$374K 0.08% 280
2025
Q1
$5.95M Sell
179,187
-5,324
-3% -$185K 0.08% 314
2024
Q4
$6.39M Buy
+184,511
New +$6.47M 0.08% 281

Other funds holding RECS

Atria Investments's RECS Position: Q1 2026 in Review

Atria Investments reduced its Columbia Research Enhanced Core ETF (RECS) stake by 1.5% in Q1 2026, selling an estimated $119K and leaving 192,402 shares worth $7.5M. The position accounts for 0.08% of the portfolio, ranked #258.

Atria Investments first reported a position in RECS in Q4 2024 and has held it in 6 quarters since. The position peaked at $8.43M in Q3 2025. 175 funds tracked by Wall St. Rank hold RECS as of Q1 2026.

  • Atria Investments held 192,402 shares of Columbia Research Enhanced Core ETF worth $7.5M as of Q1 2026.
  • Atria Investments sold 2,922 Columbia Research Enhanced Core ETF shares in Q1 2026, an estimated $119K.
  • Columbia Research Enhanced Core ETF made up 0.08% of Atria Investments's portfolio in Q1 2026, its #258 holding.
  • Atria Investments first reported a position in Columbia Research Enhanced Core ETF in Q4 2024 and has held it in 6 quarters since.
  • Atria Investments's Columbia Research Enhanced Core ETF position peaked at $8.43M in Q3 2025.
  • 175 funds tracked by Wall St. Rank held Columbia Research Enhanced Core ETF as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.